Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISLE-1: HDV Insulin Lispro in Type 1 Diabetes
NCT02794155Phase 2Completed
- Sponsor
- Diasome Pharmaceuticals
- Start
- Jun 2016
- Primary completion
- Apr 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of insulin lispro in type 1 diabetes mellitus (T1D), sponsored by Diasome Pharmaceuticals. Started Jun 2016; status: completed.
02
Drugs
insulin lispro
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02794155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02794155.